Douglas Drevets to Sepsis
This is a "connection" page, showing publications Douglas Drevets has written about Sepsis.
Connection Strength
0.391
-
Adverse outcomes associated with the use of drotrecogin alfa (activated) in patients with severe sepsis and baseline bleeding precautions. Crit Care Med. 2009 Jan; 37(1):19-25.
Score: 0.299
-
A multicenter evaluation of the safety of drotrecogin alfa (activated) in patients with baseline bleeding precautions. Curr Drug Saf. 2012 Feb; 7(1):3-7.
Score: 0.092